© 2026 nimisham.in
The Bombay High Court has told the Tukaram Mundhe-led Maharashtra FDA to use its powers judiciously after Cadila Pharmaceuticals challenged a ban on the sale of some medicines. The court questioned the regulator s approach and accepted its assurance to revoke
Across the pharmaceutical industry, a familiar narrative has been unfolding these days. A state government announces incentives for a new API cluster
Beijing: China opening its market to Indian products, especially pharmaceuticals, coupled with investments in New Delhi, will be good for the larger country-to-country relationship , envoy Vikram Doraiswami said on Saturday. Obviously, we would like to be able
An American woman has grabbed the Internet s attention after claiming that she was able to source a medicine for just $25 (over Rs 2,000) from India, when the same medicine would have cost her $1,000 (over Rs 95,000) in the US. In the video, Victoria explained